Hydroxychloroquine Dose and Risk of Systemic Lupus Erythematosus Flares
JAMA
.
2023 Feb 28;329(8):685-686.
doi: 10.1001/jama.2022.23159.
Authors
Fernando Caravaca-Fontán
1
,
Federico Yandian
2
,
Fernando C Fervenza
3
Affiliations
1
Department of Nephrology, Instituto de Investigación Hospital 12 de Octubre, Madrid, Spain.
2
Department of Nephrology, Hospital de Clínicas Dr Manuel Quintela, Montevideo, Uruguay.
3
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
PMID:
36853254
DOI:
10.1001/jama.2022.23159
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Hydroxychloroquine* / administration & dosage
Hydroxychloroquine* / adverse effects
Lupus Erythematosus, Systemic* / chemically induced
Risk
Symptom Flare Up
Substances
Hydroxychloroquine